BARILI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 759
EU - Europa 719
AS - Asia 181
Totale 1.659
Nazione #
US - Stati Uniti d'America 753
IE - Irlanda 212
IT - Italia 206
SE - Svezia 155
CN - Cina 141
DE - Germania 50
FI - Finlandia 25
FR - Francia 23
TR - Turchia 17
AT - Austria 12
SG - Singapore 11
UA - Ucraina 10
BE - Belgio 9
RO - Romania 6
IN - India 5
CA - Canada 4
GB - Regno Unito 4
CZ - Repubblica Ceca 3
MX - Messico 2
NL - Olanda 2
VN - Vietnam 2
AL - Albania 1
BD - Bangladesh 1
HU - Ungheria 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
TH - Thailandia 1
Totale 1.659
Città #
Dublin 212
Chandler 194
Ann Arbor 93
Ashburn 58
Parma 46
New York 38
Dearborn 33
Shanghai 33
Beijing 26
Wilmington 26
Princeton 25
Jacksonville 15
Izmir 14
Bremen 13
Milan 13
Nanjing 12
Vienna 12
Montespertoli 11
Reggio Emilia 11
Rome 11
Helsinki 10
Brussels 9
Des Moines 9
Guangzhou 9
Boardman 8
Seattle 8
Shenyang 7
Ardea 6
Bologna 6
Falls Church 6
Los Angeles 6
San Mateo 6
Tianjin 6
Focsani 5
Capo di Ponte 4
Cascina 4
Fairfield 4
Jinan 4
Nanchang 4
Sant'ilario D'enza 4
Wayne 4
Borås 3
Cortemaggiore 3
Fremont 3
Grafing 3
Hangzhou 3
Hebei 3
Hefei 3
Houston 3
Jiaxing 3
Kunming 3
Neviano degli Arduini 3
Norwalk 3
Phoenix 3
Pune 3
Santa Margherita Ligure 3
Taiyuan 3
Toronto 3
Woodbridge 3
Avrille 2
Brescia 2
Changsha 2
Dong Ket 2
Düsseldorf 2
Edinburgh 2
Frankfurt am Main 2
Modena 2
Montegaldella 2
Pisa 2
Quattro Castella 2
San Giuliano Milanese 2
Segrate 2
Sesto Fiorentino 2
Siena 2
Terni 2
Tuzla 2
Vittuone 2
Zhengzhou 2
Almaty 1
Amsterdam 1
Azcapotzalco 1
Bangalore 1
Bangkok 1
Bomporto 1
Brno 1
Brooklyn 1
Budapest 1
Campogalliano 1
Casalgrande 1
Catania 1
Chicago 1
Colle Val D'elsa 1
Council Bluffs 1
Fidenza 1
Formigine 1
Fuzhou 1
Gunzenhausen 1
Haikou 1
Kocaeli 1
Leawood 1
Totale 1.139
Nome #
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 123
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer 99
Metabolic regulation of the HBV-specific T cell function 76
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 76
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 72
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 64
Differential microRNA expression in osteosarcoma cell lines with diverse metastatic potential 62
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 62
Differential microRNA expression in osteosarcoma cell with different tumorigenic behaviour 60
T cell regulation in HBV-related chronic liver disease 60
Concomitant Evaluation of Heart Period and QT Interval Variability Spectral Markers to Typify Cardiac Control in Humans and Rats 55
HBV immune-therapy: From molecular mechanisms to clinical applications 52
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 51
Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments 46
MicroRNA cloning and sequencing in osteosarcoma cell lines: Differential role of miR-93 45
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 45
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 44
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 42
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 42
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 42
Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection 41
Differential microRNA expression in osteosarcoma cell lines with diverse metastatic potential. 40
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 36
A patient with mosaic USP9X gene variant 33
Neurogenin 2 regulates progenitor cell-cycle progression and Purkinje cell dendritogenesis in cerebellar development 33
COMPOSTO E COMPOSIZIONE PER IL RIPRISTINO METABOLICO E FUNZIONALE DEI LINFOCITI NK NELL’EPATOCARCINOMA E RELATIVO METODO 31
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 30
Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birth 29
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 28
Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant 26
COMPOSTO FARMACEUTICO PER L’USO IN UN TRATTAMENTO TERAPEUTICO DELL’INFEZIONE CRONICA DA HBV E METODO PER L’IDENTIFICAZIONE DI LINFOCITI ESAURITI 26
ZFP423 Coordinates Notch and Bone Morphogenetic Protein Signaling, Selectively Up-regulating Hes5 Gene Expression 25
Zfp423/ZNF423 regulates cell cycle progression, the mode of cell division and the DNA-damage response in Purkinje neuron progenitors 24
Gene Signatures Associated with Mouse Postnatal Hindbrain Neural Stem Cells and Medulloblastoma Cancer Stem Cells Identify Novel Molecular Mediators and Predict Human Medulloblastoma Molecular Classification 23
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 21
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 13
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 12
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome 11
TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa 11
Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers 11
Success and Pitfalls of Genetic Testing in Undiagnosed Diseases: Whole Exome Sequencing and Beyond 7
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma 3
Totale 1.732
Categoria #
all - tutte 7.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 17 2
2019/2020174 29 9 7 10 12 36 13 6 25 10 12 5
2020/2021184 2 7 3 5 23 21 28 23 22 9 16 25
2021/2022217 13 8 12 33 19 11 17 10 14 6 15 59
2022/2023761 72 78 40 50 79 80 12 35 247 7 47 14
2023/2024312 19 32 13 11 31 88 46 23 16 32 1 0
Totale 1.732